About This Publication:

  • Print This Page
  • Text a Friend
  • Subscribe to an RSS Feed

Sample Content 

LOGIN
My Liebert Connect

Sign up to stay informed--receive email notifications for this journal

Human Gene Therapy

Editor-in-Chief: James M. Wilson, MD, PhD
Deputy Editor: George Dickson, BSc, PhD
Human Gene Therapy Editor: Mark A. Kay, MD, PhD
Methods Editor: Thierry VandenDriessche, PhD
Clinical Development Editor: Barry J. Byrne, MD, PhD

ISSN: 1043-0342 • Published 22 issues annually • Online ISSN: 1557-7422

Current Volume: 25

Latest Impact Factor* is 4.019

*2012 Journal Citation Reports® published by Thomson Reuters, 2013

NIH / HHMI /Wellcome Trust Policies

NIH Public Access Policy: In order to assist our authors who have NIH funding to comply with this policy, Mary Ann Liebert, Inc. publishers will deposit the final accepted paper (after copy-editing and proofreading) to PubMed Central (PMC) on behalf of the authors.  Authors need not take any action. The manuscript's public access posting on PMC will occur 12 months after final publication. This service is provided free of charge.  Please note that authors may not deposit manuscripts directly to PMC or other sites without permission from Mary Ann Liebert, Inc.

Authors who would like their papers to be posted on Liebertpub.com immediately without this embargo period will have the option to make their articles available free on line via Liebert Open Option for a one-time fee of $3,200. This fee also makes the article free in perpetuity on the Liebertpub.com site. If you've received NIH funding we will also immediately deposit your paper to PMC.

Authors Funded by HHMI and Wellcome Trust: Please follow the instructions for Liebert Open Option above.

If you have any questions, please contact AuthorServices@liebertpub.com

The views, opinions, findings, conclusions and recommendations set forth in any Journal article are solely those of the authors of those articles and do not necessarily reflect the views, policy or position of the Journal, its Publisher, its editorial staff or any affiliated Societies and should not be attributed to any of them.

Recommended Publications

You may be interested in the following publications:

    Tissue Engineering, Parts A, B, & C

    Tissue Engineering, Parts A, B, & C

    The preeminent, biomedical journal bringing together the principles of engineering and life sciences to advance the field with cutting-edge research and applications on all aspects of tissue growth and regeneration.

    Nucleic Acid Therapeutics

    Nucleic Acid Therapeutics

    formerly Oligonucleotides

    Focuses on cutting-edge research and applications to find and examine new approaches using nucleic acids in therapeutics including oligonucleotides, gene modification, aptamers, RNA nanoparticles, ribozymes, and more.

    Stem Cells and Development

    Stem Cells and Development

    Globally recognized as the trusted source for critical, even controversial coverage of emerging hypotheses and novel findings on stem cells of all tissue types and their potential therapeutic applications.

    Zebrafish

    Zebrafish

    Solely focused on disseminating the latest cutting-edge advances in the zebrafish as a model organism for the study of vertebrate development, with attention to other aquarium species including medaka, Fugu, and Xiphophorus.

Browse All Publications »